Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.0667
-0.5133 (-88.50%)
Sep 24, 2026, 4:00 PM EST
Orgenesis Employees
Orgenesis had 77 employees as of December 31, 2024. The number of employees decreased by 69 or -47.26% compared to the previous year.
Employees
77
Change (1Y)
-69
Growth (1Y)
-47.26%
Revenue / Employee
$13,442
Profits / Employee
-$625,519
Market Cap
653.63K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 77 | -69 | -47.26% | 77 | 0 |
| Dec 31, 2023 | 146 | -21 | -12.57% | 146 | 0 |
| Dec 31, 2022 | 167 | 16 | 10.60% | 167 | 0 |
| Dec 31, 2021 | 151 | 40 | 36.04% | 151 | 0 |
| Dec 31, 2020 | 111 | -198 | -64.08% | 111 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| Emmaus Life Sciences | 33 |
| Aditxt | 26 |
| Reviva Pharmaceuticals Holdings | 14 |
| Hepion Pharmaceuticals | 2 |
Orgenesis News
- 4 months ago - Orgenesis Proxy statement: Proxy filing - Filings
- 4 months ago - Orgenesis Proxy statement: Proxy filing - Filings
- 5 months ago - Orgenesis Proxy statement: Proxy filing - Filings
- 6 months ago - Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - Newsfile Corp
- 6 months ago - Orgenesis Annual report: Q4 2024 - Filings
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis secures $5M equity investment from Williamsburg Venture - TheFly
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire